Exchange: NYSE·Updated 07:35 PM EDT

TMO News

News
all
press releases
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
BDSX advances two blood-based MRD programs with Bio-Rad and Thermo Fisher to broaden access to cancer monitoring.
Zacks
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
BDSX advances two blood-based MRD programs with Bio-Rad and Thermo Fisher to broaden access to cancer monitoring.
Zacks
More News
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m. ET. During the call...
Business Wire
Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4
AI adoption is reshaping medical devices, with ISRG, TEM and TMO leveraging AI to advance precision medicine and drug development.
Zacks
Here's How Much $1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 5.05% on an annualized basis producing an average annual return of 18.44%. Currently, Thermo Fisher Scientific has a marketread more...
Benzinga
Beat the Market Like Zacks: PBF, Palantir, Adobe in Focus
Market uncertainty persists, but Zacks highlights strong gains across key portfolios and stocks, including PBF, PLTR and ADBE
Zacks
Thermo Fisher Scientific (TMO) is Positioned for Resurgence
Thermo Fisher Scientific (TMO) is Positioned for Resurgence...
Yahoo! Finance: News
The Zacks Analyst Blog Highlights Cisco, Lam, Thermo Fisher Scientific, Ampco-Pittsburgh and Catalyst
Cisco, Lam Research and Thermo Fisher highlight AI, networking and life-science demand, while microcaps Ampco-Pittsburgh and Catalyst Bancorp offer added depth.
Zacks
Top Stock Reports for Cisco, Lam Research & Thermo Fisher
Cisco, Lam Research and Thermo Fisher headline today's research reports, with AI demand, customer activity and growth strategies in focus.
Zacks
Thermo Fisher CEO Says AI Will Drive More Pharma Spending — Sees 7% Organic Growth By 2028
In an interview with CNBC on Tuesday, Marc Casper said AI is helping drugmakers identify ineffective medicines quicker while also shortening the time to market for promising therapies.
Stocktwits

Advertisement|Remove ads.